Research Reports Initiated on Healthcare Stocks Patient Home Monitoring, Avivagen, Pediapharm, and Hamilton Thorne

LONDON, UK / ACCESSWIRE / August 19, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include Patient Home Monitoring, Avivagen, Pediapharm, and Hamilton Thorne. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

On Thursday, August 18, 2016, the TSX Composite Index edged 0.01% lower, to finish the session at 14,695.68. The TSX Venture Composite index, on the other hand, finished the day 1.10% higher at 837.58.

The Healthcare Index was trending down 1.10% at the close of yesterday’s session, ending the day at 85.01.

Active Wall St. has initiated research reports on the following equities: Patient Home Monitoring Corporation (TSX-V: PHM), Avivagen Inc. (TSX-V: VIV), Pediapharm Inc. (TSX-V: PDP), and Hamilton Thorne Ltd. (TSX-V: HTL). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Patient Home Monitoring Corp. (TSX-V: PHM)

On Thursday, shares in Sherman Oaks, California headquartered Patient Home Monitoring Corp. recorded a trading volume of 866,067 shares. The stock ended the day 2.17% higher at $0.23. Shares in Patient Home Monitoring, which provides and rents in-home monitoring equipment, supplies, and services for patients in the US, have surged 41.18% in the last one month. The Company is trading above its 50-day moving average. The stock’s 200-day moving average of $0.29 is above its 50-day moving average of $0.20. See our research report on PHM.V at: http://www.activewallst.com/registration-3/?symbol=PHM.

Avivagen Inc. (TSX-V: VIV)

Ottawa, Canada headquartered development stage biotechnology company, Avivagen Inc.’s stock finished Thursday’s session 4.00% higher at $0.13 with a total volume of 697,675 shares traded. Over the last one month and the previous three months, Shares of Avivagen, which designs, develops, manufactures, markets, and supports natural health products for livestock and companion animals in Canada, the US, Europe, and globally, have surged 44.44% and 85.71%, respectively. Furthermore, the stock has rallied 116.67% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Avivagen’s 50-day moving average of $0.11 is above its 200-day moving average of $0.07. The complimentary research report on VIV.V at: http://www.activewallst.com/registration-3/?symbol=VIV.

Pediapharm Inc. (TSX-V: PDP)

Verdun, Canada headquartered Pediapharm Inc.’s stock surged 10.87%, to close the day at $0.25. The stock recorded a trading volume of 148,770 shares, which was above its three months average volume of 146,034 shares. Shares of Pediapharm, which operates as a specialty pharmaceutical company in Canada, have gained 2.00% in the last one month and 50.00% in the past three months. The company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $0.22 is greater than its 200-day moving average of $0.19. Register for free and access the latest research report on PDP.V at: http://www.activewallst.com/registration-3/?symbol=PDP.

Hamilton Thorne Ltd. (TSX-V: HTL)

On Thursday, shares in Toronto, Canada based Hamilton Thorne Ltd. ended the session flat at $0.20 with a total volume of 103,929 shares traded. Shares of Hamilton Thorne, which together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets, have gained 11.11% in the last one month. The stock is trading above its 50-day moving average. The company’s 200-day moving average of $0.20 is greater than its 50-day moving average of $0.19. Hamilton Thorne’s shares traded at a PE ratio of 14.29. Get free access to your research report on HTL.V at: http://www.activewallst.com/registration-3/?symbol=HTL.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 444029